Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer.
- Author:
Koji MATSUO
1
;
Hiroko MACHIDA
;
Andrea MARIANI
;
Rachel S MANDELBAUM
;
Gretchen E GLASER
;
Bobbie S GOSTOUT
;
Lynda D ROMAN
;
Jason D WRIGHT
Author Information
- Publication Type:Original Article
- Keywords: Ovarian Neoplasms; Early-stage; Lymph Node Excision; Adequate; Trend; Survival
- MeSH: Epidemiology; Female; Humans; Lymph Node Excision*; Mortality; Mucins; Observational Study; Ovarian Neoplasms*; Retrospective Studies; Urinary Bladder Neoplasms
- From:Journal of Gynecologic Oncology 2018;29(5):e69-
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVE: To examine the trends and survival for women with early-stage epithelial ovarian cancer who underwent adequate lymphadenectomy during surgical treatment. METHODS: This is a retrospective observational study examining the Surveillance, Epidemiology, End Results program between 1988 and 2013. We evaluated 21,537 cases of stage I–II epithelial ovarian cancer including serous (n=7,466), clear cell (n=6,903), mucinous (n=4,066), and endometrioid (n=3,102) histology. A time-trend analysis of the proportion of patients who underwent adequate pelvic lymphadenectomy (≥ 8 per Gynecologic Oncology Group [GOG] criteria, ≥ 12 per Collaborative Group Report [CGR] criteria for bladder cancer, and > 22 per Mayo criteria for endometrial cancer) and a survival analysis associated with adequate pelvic lymphadenectomy were performed. RESULTS: There were significant increases in the proportion of women who underwent adequate lymphadenectomy: GOG criteria 3.6% to 28.6% (1988–2010); CGR criteria 2.4% to 22.4% (1988–2013); and Mayo criteria 0.7% to 9.5% (1988–2013) (all, p < 0.05). On multivariable analysis, adequate lymphadenectomy was independently associated with improved cause-specific survival compared to inadequate lymphadenectomy: GOG criteria, adjusted-hazard ratio (HR)=0.75, CGR criteria, adjusted-HR=0.77, and Mayo criteria, adjusted-HR = 0.85 (all, p < 0.05). Compared to inadequate lymphadenectomy, adequate lymphadenectomy was significantly associated with improved cause-specific survival for serous (HR range = 0.67–0.73), endometrioid (HR range = 0.59–0.61), and clear cell types (HR range = 0.66–0.73) (all, p < 0.05) but not in mucinous type (HR range = 0.80–0.91; p > 0.05). CONCLUSION: Quality of lymphadenectomy during the surgical treatment for early-stage epithelial ovarian cancer has significantly improved. Adequate lymphadenectomy is associated with a 15%–25% reduction in ovarian cancer mortality compared to inadequate lymphadenectomy.
